drugset / Trial / NCT01079663
The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to assess the efficacy and the safety of Chlorhexidine Gluconate chip (Periochip®) versus Placebo Chip in treatment of symptoms in patients with Peri-Implantitis.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-10
- Completion
- 2011-11
Outcome
Missed primary endpoint
registry analysis (superiority test); Chlorhexidine Chip (Periochip®) vs Placebo Chip; p = 0.1629; Mean Difference (Final Values) -0.49 (95% CI -1.19 to 0.20); Mixed Models Analysis NCT01079663 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chlorhexidine gluconate | Other / unclassified | 2.5 mg | Other |